KIMBERLY GRAY: Open Payments
NPI 1770749087 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 16 payments from 10 companies in 2025. Trend: 2023 $242 · 2024 $334 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $76 |
| Novo Nordisk Inc | 3 | $66 |
| Exact Sciences Corporation | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: UBRELVY, Wegovy, The Cologuard Plus Collection Kit, Rybelsus, AIRSUPRA, TRINTELLIX, MOUNJARO, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
